Balchem Brings New Branded Ingredient Research to SupplySide Global 2026

Balchem says it will return to SupplySide Global 2026, October 28–30 in Las Vegas, to highlight branded ingredients backed by newly published research.¹ The company, which announced its plans September 30, says its booth 5565 presence will address growing interest in daily performance, long-term vitality, and GLP-1 companion products.

“Today, ingredients need to do more than deliver efficacy. They need to earn trust,” stated Dominik Mattern, vice president of marketing, business development and science, Balchem Human Nutrition and Health. “At SupplySide Global, we're demonstrating how scientific validation, trusted branded ingredients, and direct consumer activation can work together. From clinical research to partnerships with organizations such as the New York Jets and FC Bayern Women, we're showing how ingredient brands can help convert science into consumer demand.”

What Research Will Balchem Highlight?

Balchem says it will spotlight recent studies across its portfolio. For K2VITAL, which the company describes as a patented vitamin K2 MK-7 that is typically 99.8% all-trans, the research includes work on cardiovascular health and potential post-exercise neuromuscular signaling support in older adults.

For VitaCholine, Balchem cites what it calls the first fMRI study showing how the choline ingredient influences brain network efficiency in postmenopausal women. The paper cited in the release is described as a pilot study. The company also plans to present new data on Optifolin+, a choline-enriched folate, and new research on OptiMSM® and female athletic performance.

Which Products and Formats Will Be Featured?

Albion Minerals’ Creatine MagnaPower combines creatine and magnesium in one formulation, which Balchem says delivers superior muscular performance benefits. The company will also show its Albion Meta Mag magnesium bisglycinate range, including a new high-density form designed for capsules.

On the beverage side, Balchem plans concepts including a VitaCholine-fortified Charged Frappé Coffee and VitalBlend, a customizable lipid-based powder technology. Visitors can also sample protein-enriched chocolate clusters made with Milk Protein Z-Crisps. For the first time at the show, Balchem Animal Nutrition & Health will host a pet corner.

Where Can Attendees Hear From Balchem?

Jason Wielgoszinski, sales director for powders at Balchem, will present “Unlocking Opportunities for Fortification: Trends, Applications and Innovation in Functional Foods & Beverages” on Thursday, October 29, from 11:30 to 11:50 a.m. PDT. The talk will take place at Product Development Theater A, booth 7915.

What Do Earlier Findings Say About Optifolin+?

Nutritional Outlook reported in September on a laboratory study of Optifolin+ conducted with researchers at the University of Arkansas for Medical Sciences and published in the Journal of Dietary Supplements.² The study exposed human liver cells to the ingredient for 96 hours. According to Balchem’s summary, intracellular S-adenosylmethionine rose 71% and DNA methylation activity increased by up to 14-fold compared with controls.

The article noted that Balchem’s figures for a 98% methyl capacity and a sevenfold methyl agent advantage over other folates were internally calculated. It also said the cell-model findings describe biological plausibility, not confirmed effects in people, and that no human methylation trial of the ingredient had been published.

A separate crossover study in 24 healthy adults found Optifolin+ reached peak blood concentrations faster and produced higher folate status markers than folic acid, but did not measure methylation.

What Else Has Balchem Done to Support Its Epigenetic Messaging?

Balchem also renewed its sponsorship of Oregon State University’s Linus Pauling Institute in July, according to Nutritional Outlook coverage.³ The partnership will fund videos, fact sheets, and infographics on iron nutrition and epigenetic health through the institute’s Micronutrient Information Center, some of them in Spanish. Eric Ciappio, PhD, RD, Balchem’s senior manager of nutrition science, said the company aims to clarify the role of iron bioavailability and raise awareness of the epigenetic processes that influence gene expression. The article added that Balchem describes folate, choline, and MSM as methyl donors that contribute to the body’s methyl pool.

References

1. Balchem. From clinical evidence to consumer demand: Balchem highlights the power of branded ingredients at SupplySide Global 2026. Press release. September 30, 2026.
2. Saraceno N. Preclinical cell study suggests choline-enriched folate form may boost methylation activity. Nutritional Outlook. September 14, 2026. Accessed October 16, 2026. https://www.nutritionaloutlook.com/view/preclinical-cell-study-suggests-choline-enriched-folate-boost-methylation-activity
3. McEvoy E. Balchem renews Linus Pauling Institute partnership to advance iron and epigenetic health education. Nutritional Outlook. July 23, 2026. Accessed October 16, 2026. https://www.nutritionaloutlook.com/view/balchem-linus-pauling-institute-partnership-iron-epigenetic